INDRAMEDCO

Indraprastha Medical Corporation Share Price

 

 

Invest in Indraprastha Medical Corporation with 2.05X leverage

Invest with MTF

Performance

  • Low
  • ₹457
  • High
  • ₹474
  • 52 Week Low
  • ₹307
  • 52 Week High
  • ₹641
  • Open Price₹469
  • Previous Close₹469
  • Volume132,530

Investment Returns

  • Over 1 Month -9.96%
  • Over 3 Month + 0.57%
  • Over 6 Month + 15.45%
  • Over 1 Year -6.93%

Smart Investing Starts Here Start SIP with Indraprastha Medical Corporation for Steady Growth!

Invest Now

Indraprastha Medical Corporation Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 24.1
  • PEG Ratio
  • 1.3
  • Market Cap Cr
  • 4,220
  • P/B Ratio
  • 6.4
  • Average True Range
  • 17.73
  • EPS
  • 19.06
  • Dividend Yield
  • 1
  • MACD Signal
  • -16.69
  • RSI
  • 38.81
  • MFI
  • 44.91

Indraprastha Medical Corporation Financials

Indraprastha Medical Corporation Technicals

EMA & SMA

Current Price
₹460.30
-8.65 (-1.84%)
pointer
  • Bearish Moving Average 15
  • Bullish Moving Average 1
  • 20 Day
  • ₹481.34
  • 50 Day
  • ₹499.95
  • 100 Day
  • ₹495.82
  • 200 Day
  • ₹471.24

Resistance and Support

463.9 Pivot Speed
  • R3 487.15
  • R2 480.60
  • R1 470.45
  • S1 453.75
  • S2 447.20
  • S3 437.05

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Indraprastha Medical Corporation Ltd. operates the prestigious Indraprastha Apollo Hospitals in New Delhi, providing world-class healthcare services. It offers a wide range of medical specialties, advanced diagnostics, and state-of-the-art facilities for patients from India and abroad.

Indraprastha Med. (Nse) Corp. has an operating revenue of Rs. 1,404.77 Cr. on a trailing 12-month basis. An annual revenue growth of 9% is good, Pre-tax margin of 16% is great, ROE of 26% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 86 which is a GOOD score indicating consistency in earnings, a RS Rating of 71 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 86 indicates it belongs to a poor industry group of Medical-Hospitals and a Master Score of B is close to being the best. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Indraprastha Medical Corporation Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-01 Quarterly Results
2025-08-06 Quarterly Results
2025-05-16 Audited Results & Final Dividend
2025-02-03 Quarterly Results
2024-10-30 Quarterly Results
Date Purpose Remarks
2025-09-18 FINAL Rs.4.50 per share(45%)Final Dividend
View Indraprastha Medical Corporation Dividend History Arrow

Indraprastha Medical Corporation F&O

Indraprastha Medical Corporation Shareholding Pattern

51%
2.62%
2.41%
0%
30.08%
13.89%

About Indraprastha Medical Corporation

  • NSE Symbol
  • INDRAMEDCO
  • BSE Symbol
  • 532150
  • Managing Director
  • Mr. Shivakumar Pattabhiraman
  • ISIN
  • INE681B01017

Similar Stocks to Indraprastha Medical Corporation

Indraprastha Medical Corporation FAQs

Indraprastha Medical Corporation share price is ₹460 As on 26 December, 2025 | 03:45

The Market Cap of Indraprastha Medical Corporation is ₹4219.7 Cr As on 26 December, 2025 | 03:45

The P/E ratio of Indraprastha Medical Corporation is 24.1 As on 26 December, 2025 | 03:45

The PB ratio of Indraprastha Medical Corporation is 6.4 As on 26 December, 2025 | 03:45

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23